Loading clinical trials...
Loading clinical trials...
Single Versus Multi-Dose Oral and Intravenous Tranexamic Acid in Patients at High Risk for Blood Transfusion After Spine Surgery
Conditions
Interventions
Tranexamic Acid Injectable Product (1000 mg intravenous bolus)
Vitamin C 250 MG Oral Tablet
+1 more
Locations
1
United States
Rush University Medical Center
Chicago, Illinois, United States
Start Date
August 26, 2019
Primary Completion Date
December 1, 2026
Completion Date
January 1, 2027
Last Updated
January 8, 2026
Lead Sponsor
Rush University Medical Center
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions